ICICI Prudential US Bluechip Equity Fund - IDCW - Regular Plan

Other Plans and Options
  • 3.91 %Nav, as on 12-05-2025

  • Previous Nav

  • Net Change on 12-05-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on recognized stock exchanges in the United States of America. The Scheme shall also invest in ADRs/GDRs issued by Indian and foreign companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
ICICI Prudential US Bluechip Equity Fund - IDCW 45.06 -24.42 0.66 12.48 13.47 14.83
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P 500 3.72 -6.08 8.55 12.34 14.06 7.92

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential US Bluechip Equity Fund - IDCW Jul 06, 2012 0.66 12.48 13.47 2.03 2,914.48
NIPPON INDIA - US EQUITY OPPORTUNITES FUND - IDCW Option Jul 23, 2015 7.20 15.57 13.54 2.41 642.14
NIPPON INDIA - JAPAN EQUITY FUND - IDCW Option Aug 26, 2014 11.28 11.30 9.07 2.45 262.50

Fund Holdings as on 30-April-2025

  • Huntington Ingalls Industries Inc

  • West Pharmaceutical Services Inc

  • Boeing Co

  • Brown-Forman Corp

  • Corteva Inc

  • Veeva Systems Inc

  • Pfizer Inc

  • Monolithic Power Systems Inc

  • Zimmer Biomet Holdings Inc

  • Allegion plc

  • Walt Disney

  • MarketAxess Holdings Inc

  • Campbell Soup Co

  • Danaher Corp

  • Microchip Technology Inc.

  • US Bancorp Inc

  • International Flavors & Fragrances Inc

  • Constellation Brands Inc

  • Agilent Technologies Co Ltd

  • Nike Inc

  • NXP Semiconductors NV

  • GE HealthCare Technologies Inc

  • Adobe Inc

  • TRANSUNION

  • United Parcel Service Inc

  • Estee Lauder Cos Inc

  • Bio-Rad Laboratories Inc

  • Alphabet Inc

  • Cadence Design Systems Inc

  • Mondelez International Inc

  • Bristol-Myers Squibb Co

  • Synopsys Inc

  • Northrop Grumman Corp

  • Charles Schwab Corp

  • Microsoft Corp

  • Equifax Inc.

  • Manhattan Associates Inc

  • Amazon com

  • Merck & Co Inc

  • Thermo Fisher Scientific Inc

  • Oracle Corp

  • Lam Research Corporation

  • Masco Corp.

  • Applied Material (US)

  • Autodesk

  • Amgen Inc

  • Biogen Inc

  • TREPS

  • Kenvue Inc

  • Comcast Corporation

  • TERADYNE INC

  • IDEX Corp

  • Salesforce.Com Inc

  • Net Current Assets

  • Gilead Sciences Inc.

  • Qualcomm Inc.

  • Occidental Petroleum Corp

  • Freeport-McMoRan Inc

  • Epam Systems Inc

  • Medtronic Plc

  • Altria Group Inc

  • Yum China Holdings Inc.

  • ASML Holding NV-NY REG SHS

View More

  • Miscellaneous

View More

Fund Manager

  • Cash

  • Equity

View More

About ICICI Prudential US Bluechip Equity Fund

Scheme Analysis

ICICI Prudential US Bluechip Equity Fund is a Equity - Thematic Fund - Global fund and belongs to ICICI Prudential Mutual Fund. It was launched on 06-Jul-2012 and currently has an AUM of ₹2,914.48 crore. ICICI Prudential US Bluechip Equity Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P 500 as secondary index.

The NAV of ICICI Prudential US Bluechip Equity Fund ended up ₹2.31(3.91%)yesterday to ₹61.39.

Among its top 3 holdings the fund has exposure to Huntington Ingalls Industries Inc, and

The ICICI Prudential US Bluechip Equity Fund is managed by Ritesh Lunawat and Sharmila Dmello.

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100